Related Experiment Video
Updated: Apr 15, 2026

10:17
An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
7.6K
Accelerated triglyceride secretion. A metabolic consequence of obesity
The Journal of Clinical Investigation
|July 1, 1973
Summary
Obesity accelerates triglyceride secretion in sand rats, potentially driven by increased insulin levels. This animal model provides evidence linking obesity to higher triglyceride levels, relevant to human health.
Area of Science:
- Metabolic research
- Animal modeling
- Endocrinology
Background:
- Obesity is linked to hypertriglyceridemia.
- The mechanisms driving this association require further investigation.
- Endogenous triglyceride secretion plays a key role in lipid metabolism.
Purpose of the Study:
- To develop and utilize a novel animal model to investigate the impact of obesity on endogenous triglyceride secretion.
- To explore the potential role of hyperinsulinemia in mediating the relationship between obesity and triglyceride secretion.
Main Methods:
- Developed a new animal model using desert sand rats (Psammomys obesus) that spontaneously develop obesity and hyperinsulinemia.
- Administered intravenous Triton to measure in vivo triglyceride secretion rates (TGSR).
- Correlated body weight, plasma insulin levels, and TGSR in a cohort of 18 animals; prospectively studied 7 animals before and after obesity induction.
Main Results:
- Obesity was significantly associated with accelerated endogenous triglyceride secretion (TGSR).
- Higher body weight and plasma insulin levels correlated positively with increased TGSR.
- Prospective studies confirmed that obesity induction led to increases in weight, insulin, TGSR, and basal triglyceride levels.
Conclusions:
- Obesity in sand rats leads to accelerated endogenous triglyceride secretion.
- Hyperinsulinemia may be the mechanism by which obesity enhances triglyceride secretion.
- This model provides in vivo evidence supporting a link between obesity, hyperinsulinemia, and hypertriglyceridemia, potentially applicable to humans.
More Related Videos
Related Concept Videos
Fats as Energy Storage Molecules
27.6K
Triglycerides are a form of long-term energy storage molecules. They are made of glycerol and three fatty acids. To obtain energy from fat, triglycerides must first be broken down by hydrolysis into their two principal components, fatty acids and glycerol. This process, called lipolysis, takes place in the cytoplasm. The resulting fatty acids are oxidized by β-oxidation into acetyl-CoA, which is used by the Krebs cycle. The glycerol that is released from triglycerides after lipolysis...
27.6K
Overview of Lipid Metabolism
7.1K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
7.1K
Lipid Absorption
3.8K
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
3.8K
Obesity
1.6K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
413
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
413
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
306
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
306

